Analysts are recommending ‘buy’ on global technology company Frencken Group for its proxy to growth trends in 5G, AI, health and wellness and population aging through its blue-chip customers, says Maybank Kim Eng analyst Lai Gene Lih. This comes on the back of 3QFY2020 earnings of $13.3 million.

In a Nov 21 note, Lai maintained ‘buy’ on Frencken with a sustained target price of $1.39.

“In the short term, semiconductor equipment/analytical/automotive endmarkets, which form around 70% of sales, should provide cyclical resilience. Longer-term, we are excited by margin growth potential from deepening value-add with customers as Frencken launches a breadth of products in coming years,” says Lai.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook